5:07 PM
 | 
Apr 12, 2012
 |  BC Extra  |  Company News

Algeta exercises option to co-promote Alpharadin

Algeta ASA (OSE:ALGETA) exercised an option under a 2009 deal with Bayer AG (Xetra:BAYN) to co-promote cancer compound Alpharadin in the U.S. There was no payment associated...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >